Page 49 - Sohini Das

Sun Pharma Q3 net profit up 5.2% as sales grow in India, US markets

Company says specialty products will continue as growth driver, will scale up investment for it

Covid-19 vaccination: India may have won a major battle, says Eco Survey

97% of the country's eligible beneficiaries have been given at least one dose, while 90% have got two doses

Alkem launches novel antibiotic combination for drug-resistant infections

The formulation, to be sold under the Zidavi brans for Rs 2,700 a vial, has been approved by US FDA, European Medicines Agency, and CDSCO

Focus mustn't waver, we must continue to invest in health: K Srinath Reddy

We have to create a multi-layered, multi-skilled health workforce. This is good even from the point of view of employment generation, says PHFI founder

Will raise Chennai unit output to curtail waiting period: BMW's Pawah

Indian market is probably at its take-off point, says Vikram Pawah

India Inc looks to plug into EV-charging infrastructure at work

Firms offering such vehicles as car lease options, converting their fleet into EVs

JK Tyre launches specialised product range, sees demand from EV, SUVs

Company launches smart tyres that give real-time updates about pressure, temperature and punctures to phone app

Bharat Biotech rolls out India's first intra-nasal Covid vaccine iNCOVACC

Priced at Rs 800/dose for private players, Rs 325 for bulk procurement by govts

Remembering BV Doshi, the great architect who strived to build timelessness

Pritzker awardee, Doshi blended modernist values with local ethos; the IIM-B building is an example

Torrent Pharma Q3 PAT up 14% to Rs 249 crore riding on India, Brazil

Torrent Pharma's revenues came in at Rs 2,491 crore for the quarter under review. The Ebitda margins were at 29.1 per cent while gross margins were 71 per cent during Q3FY23

DRL posts strong 77% profit growth to Rs 1,247 cr riding on US, Russia

Firm says sustained focus on improving productivity has also helped boost profits; DRL is now bullish on its biosimilars and hopes to start filing for them in US in the coming quarters

Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US

Revenue up 6% to Rs 5,810 cr; firm expects US FDA audit at Goa unit

Dialysis business in growth mode amid rising treatment demand in India

The industry estimates that there are some 20 million patients with chronic kidney disease in India, but only 20 per cent get dialysis treatment

Lupin Digital launches Lyfe, a 24x7 monitoring ecosystem for heart patients

Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and offline modules

Bharat Biotech starts voluntary recall of rabies vaccine after batch theft

Company had tested the batch and released it, but part of it was stolen, for which cold chain storage integrity was unknown. Decision made to recall the entire batch

Hero Electric looks to raise nearly Rs 2,000 crore to drive expansion

The company is not looking for mergers and acquisitions, but is open to having a strategic investor who can bring some technical expertise

Bajaj Auto's electric Chetak to roll out in Europe by early 2024

Company's Chakan plant has just produced its 1 millionth KTM bike

Sun Pharma to acquire US-based Concert Pharmaceuticals for $576 million

Deal size could expand to $827 mn if additional milestone-based payments are made

Pharma, healthcare Q3FY23 preview: Cost pressures abating to aid margins

Hospitals are expected to report a soft Q3 result due to a mix of seasonality and easing pent-up demand, however, average revenue per occupied bed is likely to remain steady

Cipla launches diagnostic device, says it will provide results in minutes

Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility